#pharmaceuticals

Collection of pharmaceuticals news, found 364 news.

Abbott to Separate into Two Leading Companies in Diversified Medical Products

-     Two publicly traded companies will offer shareholder distinct opportunities given unique ...

S1P1 Agonists are Currently Indicated For Treatment of Multiple Sclerosis

-     S1P1 LEAD COMPOUNDS, AMG 369 AND AMG 277, WILL BE OFFERED FOR SALE AT A DECEMBER 8, 2011 ...

S1P1 Lead Compounds, AMG 369 and AMG 277, Will Be Offered for Sale at a December 8, 2011 Sealed Bid

-     Joseph F. Finn, Jr., C.P.A. ("Finn") Assignee for the Benefit of Creditors of Epix ...

'Youth in Europe' Drug Prevention Programme Sees Youth Drinking Drop From 42% to 9%

-        Iceland and Actavis continue to support the fight against substance ...

S1P1 Program Assets Generated by Epix Pharmaceuticals, Inc. and Amgen Will Be Offered for Sale

-    Joseph F. Finn, Jr., C.P.A. ("Finn") Assignee for the Benefit of Creditors of Epix Pharmaceuticals, ...

Roche and Diagnostica Stago Terminate Partnership

-         Roche Professional Diagnostics and Diagnostica Stago announced today that the ...

New ESC Guidelines Recommend Efient(R) (Prasugrel) as First-line Antiplatelet Therapy for Patients w

-    In new guidelines from the European Society of Cardiology (ESC), prasugrel - a once daily oral ...

Effient(R) (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopido

-Analysis evaluated efficacy and safety among three patient sub-groups        A new ...

Eli Lilly India and Lupin Announce Strategic Collaboration to Help Fight the Battle Against Diabetes

-    Eli Lilly India (Lilly) and Lupin Limited (Lupin) today announced they have entered into a ...

Jubilant and Endo Pharmaceuticals Announce Late Stage Discovery Milestone in Oncology Program

-    Jubilant Biosys Ltd., Bengaluru based subsidiary of Jubilant Life Sciences Ltd., and Endo ...

Synthes and Lilly Sign Development and Collaboration Agreement

-        Synthes, Inc. (SIX: SYST.VX) and Eli Lilly and Company (NYSE: LLY) today ...

Edison Pharmaceuticals to Provide Expanded Access to EPI-743 for Mitochondrial Disease

-FDA allows use of investigational new drug for life-threatening indications     Edison ...

Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug Designation

-Designation covers inherited respiratory chain diseases of the mitochondria    Edison Pharmaceuticals, ...

Ashland to Acquire International Specialty Products Inc. (ISP)

-     Broadens Global Leadership in Specialty Chemicals     Ashland Inc. (NYSE: ...

Wes Wheeler Appointed as CEO by Marken's Board of Directors

-        The Marken Board of Directors is pleased to announce the appointment of Wesley ...